238428-26-7

Basic information

• Product Name: 3-(Methylsulfonylamino)benzylamine Hydrochloride
• Synonyms: 3-(Methylsulfonylamino)benzylamine Hydrochloride;methanesulfonamide hydrochloride;N-(3-(Aminomethyl)
• CAS NO: 238428-26-7
• Molecular Formula: C₈H₁₂N₂O₂S*ClH
• Molecular Weight: 236.722
• Mol File: 238428-26-7.mol

Chemical Properties

• Boiling Point: 380.9°C at 760 mmHg
• Flash Point: 184.2°C
• Appearance: /
• Vapor Pressure: 3.56E-06mmHg at 25°C
• CAS DataBase Reference: 3-(Methylsulfonylamino)benzylamine Hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(Methylsulfonylamino)benzylamine Hydrochloride(238428-26-7)
• EPA Substance Registry System: 3-(Methylsulfonylamino)benzylamine Hydrochloride(238428-26-7)

Safety Data

• Hazardous Substances Data: 238428-26-7(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
3-(Methylsulfonylamino)benzylamine Hydrochloride is used as a reagent in organic synthesis for its ability to facilitate various chemical reactions, contributing to the formation of complex organic molecules.
Used in Pharmaceutical Production:
In the pharmaceutical industry, 3-(Methylsulfonylamino)benzylamine Hydrochloride is used as a building block for the development of new drugs, leveraging its chemical properties to create molecules with potential therapeutic effects.
Used in Agrochemical Development:
3-(Methylsulfonylamino)benzylamine Hydrochloride is utilized in the agrochemical sector as a component in the synthesis of compounds designed to protect crops and enhance agricultural productivity.
Used in Fine Chemicals Manufacturing:
3-(Methylsulfonylamino)benzylamine Hydrochloride is also used in the production of fine chemicals, where its unique properties allow for the creation of high-quality specialty chemicals for various applications.
Used in Drug Research and Development:
3-(Methylsulfonylamino)benzylamine Hydrochloride is employed in drug research as a potential drug candidate, with ongoing studies exploring its biological activities and therapeutic potential in treating various conditions.

InChI:InChI=1/C8H12N2O2S.ClH/c1-13(11,12)10-8-4-2-3-7(5-8)6-9;/h2-5,10H,6,9H2,1H3;1H

Upstream product

• 147291-66-5 3-tert-butoxycarbonylaminomethylaniline 
• 147291-65-4 N-(3-nitrophenylmethyl)carbamic acid t-butyl ester 
• 26177-43-5 3-nitrobenzylamine hydrochloride 
• 238427-66-2 N-(tert-butyloxycarbonyl)-3-methylsulfonamidobenzylamine 

Downstream Products

• 1342278-41-4 N-(3-((3-(4-(pyridin-4-yl)thiazol-2-yl)ureido)methyl)phenyl)methanesulfonamide hydrochloride 

Relevant articles and documents

AGONISTS THAT ENHANCE BINDING OF INTEGRIN-EXPRESSING CELLS TO INTEGRIN RECEPTORS

A method of enhancing binding of cells to an integrin-binding ligand comprises treating integrin-expressing cells in vitro with an agonist of integrin, wherein the integrin is selected from the group consisting of α4β1, α5β1, α4β7, αvβ3 and αLβ2, and contacting the treated cells with an integrin-binding ligand; integrin agonist compounds having the general formula I; methods of treating integrin-expressing cells with such agonists to enhance binding; and therapeutic methods comprising administering agonist-treated cells or agonist compounds to a mammal.

Multicyclic bis-amide MMP inhibitors

The present invention relates generally to bis-amide group containing pharmaceutical agents, and in particular, to multicyclic bis-amide MMP-13 inhibitor compounds. More particularly, the present invention provides a new class of MMP-13 inhibiting compounds, containing a pyrimidinyl bis-amide group in combination with a heterocyclic moiety, that exhibit an increased potency and solubility in relation to currently known bis-amide group containing MMP-13 inhibitors.